+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Viscosupplementation Market by Product Type, Application Area, Distribution Channel, End User - Global Forecast to 2030- Product Image
Viscosupplementation Market by Product Type, Application Area, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Viscosupplementation Market by Product Type, Application Area, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4986027
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Viscosupplementation Market grew from USD 3.01 billion in 2024 to USD 3.20 billion in 2025. It is expected to continue growing at a CAGR of 6.22%, reaching USD 4.32 billion by 2030.

Unveiling the Potentials of Viscosupplementation

Viscosupplementation has emerged as a cornerstone therapy for managing osteoarthritis by restoring joint lubrication and alleviating pain through the intra-articular administration of hyaluronic acid. This introduction sets the stage for understanding how advanced formulations are reshaping patient outcomes and therapeutic approaches. As degenerative joint conditions become increasingly prevalent in aging populations worldwide, healthcare stakeholders are evaluating viscosupplementation not merely as a palliative measure but as a strategic intervention to delay disease progression and enhance quality of life.

This summary distills key insights from recent developments in product design, regulatory frameworks, and clinical adoption. By examining market drivers, transformative trends, and emerging challenges, readers will gain a holistic view of the competitive landscape. The narrative progresses from foundational concepts to segmented analyses, regional dynamics, and corporate strategies, equipping decision-makers with the contextual knowledge necessary to navigate complex market forces. Transitioning seamlessly from broad market perspectives to granular segmentation, this section underscores the pivotal role of innovation in delivering targeted joint health solutions.

Emerging Trends Redefining the Viscosupplementation Landscape

The viscosupplementation landscape is undergoing transformative shifts driven by a convergence of scientific innovation and evolving patient expectations. Advances in molecular engineering have led to the development of cross-linked hyaluronic acid formulations that offer extended residence time within the joint space, reducing injection frequency and enhancing patient adherence. Simultaneously, improvements in non-cross-linked variants across high, medium, and low molecular weights are enabling personalized treatment regimens that address varying degrees of cartilage degeneration.

Beyond product evolution, the integration of digital health tools is redefining patient engagement and aftercare. Remote monitoring platforms and telemedicine consultations facilitate real-time assessment of therapeutic efficacy and side-effect management, streamlining follow-up protocols in both specialist clinics and home care settings. This convergence of biologic innovation and digital enablement positions viscosupplementation as a dynamic field where targeted formulations and patient-centric delivery models coalesce to drive improved clinical outcomes.

Understanding the US Tariffs Impact on Viscosupplementation Dynamics

The implementation of United States tariffs in 2025 on imported medical devices and biologics, including hyaluronic acid products, has introduced a new set of challenges and opportunities for market participants. Supply chain stakeholders have experienced upward pressure on costs, prompting producers to reassess sourcing strategies and explore localized manufacturing capacities. In response, several companies have initiated investments in domestic synthesis facilities to mitigate the impact of import duties and ensure a stable supply of high-quality viscosupplementation products.

These tariff-induced shifts have also influenced pricing negotiations with payers and providers. Healthcare systems, facing increased procurement expenses, are demanding more robust evidence of long-term clinical benefits and cost efficiency. As a result, manufacturers are prioritizing real-world data collection and health economic studies to justify premium pricing. While short-term margin compression has triggered consolidation among smaller suppliers, larger firms are leveraging scale economies and diversified portfolios to sustain growth. Overall, the cumulative impact of the 2025 tariffs has catalyzed innovation in supply chain resilience and value demonstration across the viscosupplementation sector.

Deciphering Market Segments for Targeted Strategies

A thorough segmentation analysis reveals critical avenues for market expansion and product differentiation. In the product type domain, cross-linked hyaluronic acid formulations bifurcate into single injection and multiple injection modalities, with single injection variants gaining traction for their convenience in outpatient and specialty clinic settings. Conversely, non-cross-linked hyaluronic acid products span high, medium, and low molecular weight categories, each tailored to specific degrees of joint deterioration and patient mobility requirements.

Application area segmentation further underscores targeted therapeutic use cases, ranging from ankle and hip to knee and shoulder osteoarthritis. The knee segment remains the largest driver of adoption, attributable to its high incidence rate and established reimbursement pathways. However, emerging interest in ankle and shoulder treatments is fostering new clinical trials and provider training programs. Distribution channel insights highlight the importance of hospital pharmacies, retail pharmacies, and an increasingly sophisticated online pharmacy network offering mail order services and prescription portals. Specialty clinics, encompassing ambulatory surgical centers, orthopedic centers, and rehabilitation centers, are evolving into hubs for advanced viscosupplementation delivery and monitoring.

End user segmentation delineates opportunities in home care scenarios-both assisted administration by healthcare aides and self-administration models-as well as in institutional settings like hospitals and outpatient clinics that include orthopedic practices and rheumatology clinics. Each end user group presents unique requirements for product packaging, patient education, and post-injection support services, enabling manufacturers and service providers to tailor integrated solutions that align with distinct care pathways.

Regional Dynamics Shaping the Global Viscosupplementation Market

Regional analysis reveals differentiated growth trajectories and strategic priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, mature healthcare infrastructures and favorable reimbursement policies have driven widespread adoption of viscosupplementation, particularly in the United States and Canada. Latin American markets are beginning to mirror this trend, supported by increased regulatory harmonization and awareness campaigns.

Across Europe Middle East & Africa, the broader region presents a mosaic of healthcare systems with varying levels of access and reimbursement complexity. Western European nations continue to lead in clinical innovation and guideline integration, while Middle Eastern countries are prioritizing medical tourism and infrastructure development. Sub-Saharan Africa remains nascent but shows promise through public-private partnerships aimed at expanding orthopedic and rheumatology services.

The Asia-Pacific region is characterized by rapid market expansion fueled by sizeable patient populations in China, India, Japan, and Southeast Asia. Government-led initiatives to address aging demographics and rising osteoarthritis prevalence are accelerating approval processes and reimbursement structures. Urban centers are witnessing a surge in specialty clinics and retail pharmacy networks, positioning the region as a high-growth frontier for novel viscosupplementation offerings.

Competitive Landscape and Leading Innovators in Viscosupplementation

The competitive environment is marked by established pharmaceutical and biotech firms alongside emerging specialist producers of hyaluronic acid products. Leading innovators differentiate through proprietary cross-linking technologies, patient adherence programs, and comprehensive clinical support services that span pre-injection assessment to long-term outcomes tracking. Strategic collaborations with orthopedic societies and rheumatology associations bolster scientific credibility and facilitate guideline inclusion.

Major players are executing targeted mergers and acquisitions to expand their geographic footprint and pipeline depth, focusing on next-generation formulations designed for extended durability and enhanced viscoelastic profiles. Investments in manufacturing excellence and supply chain transparency serve as key competitive levers, especially in light of recent tariff-related disruptions. Meanwhile, agile niche companies are leveraging digital health platforms and direct-to-physician education initiatives to carve out specialized market positions in both hospital and outpatient environments.

Strategic Imperatives for Industry Leaders

To capitalize on evolving market dynamics, industry leaders should prioritize investment in advanced cross-linked hyaluronic acid formulations that reduce injection frequency and improve patient compliance. Strengthening local manufacturing capabilities will buffer against tariff volatility and enhance supply chain resilience. Engaging in outcome-based pricing agreements with payers can demonstrate real-world value, particularly when supported by rigorous post-marketing studies and patient reported outcomes.

Expanding partnerships with digital health providers will amplify remote monitoring and adherence solutions, elevating patient engagement in home care and outpatient settings. Tailoring product development and marketing strategies to specific application areas, such as shoulder or ankle osteoarthritis, will unlock niche growth opportunities. Finally, aligning distribution networks with specialist clinics, mail order services, and integrated pharmacy channels will optimize access and streamline care pathways, ensuring that viscosupplementation remains at the forefront of joint health management.

Robust Methodology Underpinning Comprehensive Insights

This comprehensive analysis is underpinned by a rigorous research methodology that integrates primary and secondary data sources. Primary research involved in-depth interviews with key opinion leaders, orthopedic surgeons, rheumatologists, and distribution channel executives to capture first-hand perspectives on clinical adoption and market access. Secondary research encompassed peer-reviewed literature, regulatory filings, company financial reports, and healthcare database analytics to validate market trends and competitive positioning.

Data triangulation ensured consistency and reliability, while proprietary modeling tools facilitated the synthesis of qualitative insights and market segmentation frameworks. Regional workshops provided validation for emerging themes and tariff impact scenarios, enriching the analysis with localized intelligence. This multi-layered approach offers stakeholders confidence in the findings and actionable recommendations, grounded in both empirical evidence and expert consensus.

Harnessing Viscosupplementation to Address Unmet Needs in Joint Health

Viscosupplementation stands at a pivotal juncture where scientific innovation, shifting regulatory landscapes, and evolving patient needs intersect. The insights presented herein illuminate the transformative shifts in formulation technology, tariff-induced supply chain adaptations, and nuanced segmentation strategies that define today’s market. Regional and competitive analyses further contextualize the landscape, offering clarity on growth hotspots and strategic imperatives.

As osteoarthritis prevalence continues to rise globally, the demand for efficacious joint health solutions will intensify. Manufacturers and service providers that proactively align with evidence-based reimbursement models, invest in outcome-driven product development, and cultivate integrated care pathways will secure a competitive edge. By leveraging the actionable recommendations and segmentation insights detailed in this summary, industry stakeholders can navigate complexity and drive sustained growth in the viscosupplementation arena.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Cross Linked Hyaluronic Acid
      • Multiple Injection
      • Single Injection
    • Non Cross Linked Hyaluronic Acid
      • High Molecular Weight
      • Low Molecular Weight
      • Medium Molecular Weight
  • Application Area
    • Ankle Osteoarthritis
    • Hip Osteoarthritis
    • Knee Osteoarthritis
    • Shoulder Osteoarthritis
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
      • Mail Order Services
      • Prescription Portals
    • Retail Pharmacies
    • Specialty Clinics
      • Ambulatory Surgical Centers
      • Orthopedic Centers
      • Rehabilitation Centers
  • End User
    • Home Care
      • Assisted Administration
      • Self Administration
    • Hospitals
    • Outpatient Clinics
      • Orthopedic Practices
      • Rheumatology Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Sanofi SA
  • Ferring International Center SA
  • Bioventus Inc.
  • Anika Therapeutics, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Seikagaku Corporation
  • LG Chem Ltd.
  • Smith & Nephew plc
  • TRB Chemedica AG

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Viscosupplementation Market, by Product Type
8.1. Introduction
8.2. Cross Linked Hyaluronic Acid
8.2.1. Multiple Injection
8.2.2. Single Injection
8.3. Non Cross Linked Hyaluronic Acid
8.3.1. High Molecular Weight
8.3.2. Low Molecular Weight
8.3.3. Medium Molecular Weight
9. Viscosupplementation Market, by Application Area
9.1. Introduction
9.2. Ankle Osteoarthritis
9.3. Hip Osteoarthritis
9.4. Knee Osteoarthritis
9.5. Shoulder Osteoarthritis
10. Viscosupplementation Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.3.1. Mail Order Services
10.3.2. Prescription Portals
10.4. Retail Pharmacies
10.5. Specialty Clinics
10.5.1. Ambulatory Surgical Centers
10.5.2. Orthopedic Centers
10.5.3. Rehabilitation Centers
11. Viscosupplementation Market, by End User
11.1. Introduction
11.2. Home Care
11.2.1. Assisted Administration
11.2.2. Self Administration
11.3. Hospitals
11.4. Outpatient Clinics
11.4.1. Orthopedic Practices
11.4.2. Rheumatology Clinics
12. Americas Viscosupplementation Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Viscosupplementation Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Viscosupplementation Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Sanofi SA
15.3.2. Ferring International Center SA
15.3.3. Bioventus Inc.
15.3.4. Anika Therapeutics, Inc.
15.3.5. Zimmer Biomet Holdings, Inc.
15.3.6. Teva Pharmaceutical Industries Ltd.
15.3.7. Seikagaku Corporation
15.3.8. LG Chem Ltd.
15.3.9. Smith & Nephew plc
15.3.10. TRB Chemedica AG
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. VISCOSUPPLEMENTATION MARKET MULTI-CURRENCY
FIGURE 2. VISCOSUPPLEMENTATION MARKET MULTI-LANGUAGE
FIGURE 3. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MULTIPLE INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MEDIUM MOLECULAR WEIGHT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ANKLE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SHOULDER OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY MAIL ORDER SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY PRESCRIPTION PORTALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ASSISTED ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC PRACTICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY RHEUMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 67. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 68. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 69. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 71. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 72. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 73. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 74. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 77. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 78. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 79. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 82. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 128. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 129. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 130. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 131. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 132. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 133. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 134. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 135. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 136. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 138. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 139. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 140. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 142. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 143. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 156. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 158. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 159. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 160. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 161. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 162. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 163. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 165. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 168. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 169. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 170. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 171. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 172. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 173. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 206. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 208. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 209. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 210. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 211. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 212. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 213. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 214. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 215. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 226. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 228. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 229. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 230. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 232. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 233. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 234. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 235. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 236. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 238. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 239. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 240. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 241. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 242. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 243. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 245. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 266. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 268. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 269. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 270. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 272. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 273. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 275. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 276. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 278. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 279. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 280. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 282. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 283. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 285. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 296. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 298. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 299. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 300. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 301. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 302. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 303. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 304. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 305. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 306. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 308. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 309. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 310. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 312. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 313. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 315. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY OUTPATIENT CLINICS, 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY NON CROSS LINKED HYALURONIC ACID, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION AREA, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SPECIALTY CLINICS, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END USER, 2018-2030 (US

Companies Mentioned

The companies profiled in this Viscosupplementation market report include:
  • Sanofi SA
  • Ferring International Center SA
  • Bioventus Inc.
  • Anika Therapeutics, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Seikagaku Corporation
  • LG Chem Ltd.
  • Smith & Nephew plc
  • TRB Chemedica AG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.2 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.32 Billion
Compound Annual Growth Rate6.2%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Viscosupplementation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Viscosupplementation Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Hyaluronic Acid Viscosupplementation - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Hyaluronic Acid Viscosupplementation - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Viscosupplementation Market 2025-2033 - Product Image

Viscosupplementation Market 2025-2033

  • Report
  • 143 Pages
  • Global
From
Viscosupplementation - Global Strategic Business Report - Product Image

Viscosupplementation - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Viscosupplementation Market, Global Forecast Report by by Product, By Application, by End User, Regions and Company Analysis 2025-2033 - Product Image

Viscosupplementation Market, Global Forecast Report by by Product, By Application, by End User, Regions and Company Analysis 2025-2033

  • Report
  • 200 Pages
  • Global
From

About the Viscosupplementation Market

Viscosupplementation is a type of orthopedic device used to treat joint pain caused by osteoarthritis. It involves injecting a gel-like substance, known as a viscosupplement, into the affected joint. The viscosupplement is designed to lubricate the joint and reduce pain and inflammation. It is typically used when other treatments, such as physical therapy and medications, have not been successful. Viscosupplementation is a relatively new technology and is becoming increasingly popular as an alternative to more invasive treatments, such as joint replacement surgery. It is generally considered to be safe and effective, with few side effects. Some of the companies in the viscosupplementation market include Zimmer Biomet, Smith & Nephew, Stryker, and DePuy Synthes. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.